California encephalitis virus
Synonyms and Keywords: CEV; CVE; California virus encephalitis; CE virus
California encephalitis virus is a mild infection of the central nervous system. California encephalitis virus belongs to the Group V negative-sense ssRNA virus within the Bunyaviridae family of viruses. It is also known as an arbovirus. California encephalitis virus is usually transmitted via mosquitos to the human host. California encephalitis virus contains negative-sense viral RNA; this RNA is complementary to mRNA and thus must be converted to positive-sense RNA by an RNA polymerase before translation. California encephalitis virus is contracted by the bite of an infected mosquito, primarily Aedes triseriatus. California encephalitis virus must be differentiated from other diseases that cause fever, headache, seizures, and altered mental status. There are approximately 70-115 cases of California encephalitis virus per year in the United States, most commonly affecting infants and children between the ages of 6 months and 15 years old. California encephalitis virus usually clears in 1 to 2 weeks and rarely recurs. Less than 1% of cases result in mortality. However, approximately 20% of patients have residual seizures. The diagnostic method of choice for California encephalitis virus is laboratory testing. There is no treatment for California encephalitis virus; the mainstay of therapy is supportive care.
California encephalitis virus was first discovered in 1943 in Kern County, California. In 1945, the first human cases of encephalitis were attributed to this new virus. Three cases in total were reported, and all three cases were Kern County residents. In all three cases there was strong laboratory evidence confirming infection, due to the presence of neutralizing antibodies linked to California encephalitis.
There is no classification system established for California encephalitis virus. California encephalitis virus belongs to the Group V negative-sense ssRNA virus within the Bunyaviridae family of viruses, and the genus Orthobunyavirus. California encephalitis virus is also known as an arbovirus, or an arthropod-borne virus. The California encephalitis serogroup, which contains genetically similar viruses such as the La Crosse virus, shares its name with the virus.
California encephalitis virus is usually transmitted via mosquitos to the human host. California encephalitis virus contains negative-sense viral RNA; this RNA is complementary to mRNA and thus must be converted to positive-sense RNA by an RNA polymerase before translation. California encephalitis virus is made up of an enveloped virion with a helically symmetrical capsid. The envelope contains G1 glycoproteins. Neutralizing antibodies against these proteins block fusion of the virus with host cells and inhibit hemagglutination. The virus genome is over 12000 nucleotides in length and consists of three segments of various sized single-stranded RNA (negative sense and ambi-sense).
California encephalitis virus is contracted by the bite of an infected mosquito, primarily Aedes triseriatus. The virus is maintained and amplified in Aedes triseriatus populations through transovarial and venereal transmission. The virus overwinters in the mosquito egg. Amplification also occurs in chipmunks and squirrels, upon which mosquitos feed. Humans are dead-end hosts for the virus, meaning there is an insufficient amount of California encephalitis virus in the blood stream to infect a mosquito. Subsequently, the disease cannot be spread to other humans. The incubation period is 5-15 days.
California encephalitis virus causes encephalitis in humans.
Differentiating California Encephalitis Virus from other Diseases
|Meningitis||Classic triad of fever, nuchal rigidity, and altered mental status||Photophobia, phonophobia, rash associated with meningococcemia, concomitant sinusitis or otitis, swelling of the fontanelle in infants (0-6 months)|
|Brain abscess||Fever, headache, hemiparesis||Varies depending on the location of the abscess; clinically, visual disturbance including papilledema, decreased sensation; on imaging, a lesion demonstrates both ring enhancement and central restricted diffusion|
|Demyelinating diseases||Ataxia, lethargy||Multiple sclerosis: clinically, nystagmus, internuclear ophthalmoplegia, Lhermitte's sign; on imaging, well-demarcated ovoid lesions with possible T1 hypointensities (“black holes”)|
|Substance abuse||Tremor, headache, altered mental status||Varies depending on type of substance: prior history, drug-seeking behavior, attention-seeking behavior, paranoia, sudden panic, anxiety, hallucinations|
|Electrolyte disturbance||Fatigue, headache, nausea||Varies depending on deficient ions; clinically, edema, constipation, hallucinations; on EKG, abnormalities in T wave, P wave, QRS complex; possible presentations include arrhythmia, dehydration, renal failure|
|Stroke||Ataxia, aphasia, dizziness||Varies depending on classification of stroke; presents with positional vertigo, high blood pressure, extremity weakness|
|Intracranial hemorrhage||Headache, coma, dizziness||Lobar hemorrhage, numbness, tingling, hypertension, hemorrhagic diathesis|
|Trauma||Headache, altered mental status||Amnesia, loss of consciousness, dizziness, concussion, contusion|
Epidemiology and Demographics
There are approximately 70-115 cases of California encephalitis virus per year in the United States.
California encephalitis virus commonly affects individuals between 6 months old and 15 years of age.
The majority of California encephalitis virus cases are reported in the summer months between July and September, and peaks in August.
The majority of California encephalitis virus cases are reported in the Midwestern United States, especially those living in rural and suburban settings surrounded by deciduous forests.
Common risk factors in the development of California encephalitis virus include:
- Young age
- Residing or working in rural and suburban settings
- Mosquito contact
- Summer season
- Outdoor activities such as camping or hunting
Natural History, Complications, and Prognosis
California encephalitis virus usually clears in 1 to 2 weeks and rarely recurs.
Common complications of California encephalitis virus include:
Prognosis for California encephalitis virus is generally good, with most individuals returning to full health in 2-3 weeks. Less than 1% of cases result in mortality. However, approximately 20% of patients have residual seizures.
History and Symptoms
If possible, a detailed and thorough history from the patient is necessary. In rare cases, California encephalitis virus presents with symptoms mimicking herpes simplex encephalitis. Common symptoms of California encephalitis virus include:
Common physical examination findings of California encephalitis virus include:
The diagnostic method of choice for California encephalitis virus is laboratory testing. Laboratory findings consistent with the diagnosis of California encephalitis virus include:
- Serologic cross-reactivity
- Presence of IgM antibodies
- Persistence of IgG and neutralizing antibodies
- Confirmation of arboviral-specific neutralizing antibodies in enzyme linked immunosorbent assay (ELISA)
On EEG, California encephalitis virus is characterized by periodic lateralizing epilepitoform discharges. However, results on imaging are not sufficient evidence to warrant California encephalitis virus diagnosis.
There is no treatment for California encephalitis virus; the mainstay of therapy is supportive care.
Surgical intervention is not recommended for the management of California encephalitis virus.
There are no available vaccines against California encephalitis virus. Primary prevention strategies include:
- Removal of standing water
- Screens on doors and windows
- When outdoors, wearing:
- Insect repellent containing DEET
- Long sleeves, pants; tucking in pants into high socks
- M.D. JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Expert Consult Premium Edition. Saunders; 2014.
- La Crosse Encephalitis. Ohio Department of Health. http://www.odh.ohio.gov/pdf/idcm/lac.pdf Accessed on February 25, 2016.
- The Management of Encephalitis: Clinical Practice Guidelines by the Infectious Diseases Society of America. http://www.idsociety.org/uploadedFiles/IDSA/Guidelines-Patient_Care/PDF_Library/Encephalitis.pdf Accessed on February 16, 2016.
- Eldridge BF, Glaser C, Pedrin RE, Chiles RE (2001). "The first reported case of California encephalitis in more than 50 years". Emerg Infect Dis. 7 (3): 451–2. doi:10.3201/eid0703.010316. PMC 2631795. PMID 11384526.
- Kennedy PG (2004). "Viral encephalitis: causes, differential diagnosis, and management". J Neurol Neurosurg Psychiatry. 75 Suppl 1: i10–5. PMC 1765650. PMID 14978145.
- Arboviral Infections (arthropod-borne encephalitis, eastern equine encephalitis, St. Louis encephalitis, California encephalitis, Powassan encephalitis, West Nile encephalitis). New York State Department of Health (2006). https://www.health.ny.gov/diseases/communicable/arboviral/fact_sheet.htm Accessed on February 23, 2016
- Eckstein C, Saidha S, Levy M (2012). "A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis". J Neurol. 259 (5): 801–16. doi:10.1007/s00415-011-6240-5. PMID 21932127.
- De Kruijk JR, Twijnstra A, Leffers P (2001). "Diagnostic criteria and differential diagnosis of mild traumatic brain injury". Brain Inj. 15 (2): 99–106. doi:10.1080/026990501458335. PMID 11260760.
- Goldman L, Schafer AI. Goldman's Cecil Medicine. Elsevier Health Sciences; 2011.
- Sokol DK, Kleiman MB, Garg BP (2001). "LaCrosse viral encephalitis mimics herpes simplex viral encephalitis". Pediatr Neurol. 25 (5): 413–5. PMID 11744319.
- Richie MB, Josephson SA (2015). "A Practical Approach to Meningitis and Encephalitis". Semin Neurol. 35 (6): 611–20. doi:10.1055/s-0035-1564686. PMID 26595861.
- "Public Health Image Library (PHIL)".